Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000899140-17-000556
Filing Date
2017-08-22
Accepted
2017-08-22 16:09:10
Documents
2
Group Members
CUBIST SYSTEMATIC STRATEGIES, LLCPOINT72 ASIA (HONG KONG) LTDPOINT72 CAPITAL ADVISORS, INC.STEVEN A. COHEN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G p21939659a.htm SC 13G 145139
2 JOINT FILING AGREEMENT p21939659b.htm EX-99.1 6466
  Complete submission text file 0000899140-17-000556.txt   153408
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Subject) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86096 | Film No.: 171045270
SIC: 2834 Pharmaceutical Preparations

Mailing Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902
Business Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902 203-890-2000
Point72 Asset Management, L.P. (Filed by) CIK: 0001603466 (see all company filings)

EIN.: 465064661 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G